高雄醫學大學圖書館 |

語系/ Language: 繁體中文

登入

回首頁

Properties of Coronavirus Spike Prot...

University of Washington.

Properties of Coronavirus Spike Proteins and the Antibody Responses Against Them /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Properties of Coronavirus Spike Proteins and the Antibody Responses Against Them // Amin Addetia.
作者:	Addetia, Amin,
面頁冊數:	1 electronic resource (263 pages)
附註:	Source: Dissertations Abstracts International, Volume: 85-10, Section: B.
提要註:	Coronaviruses have a propensity to spillover from zoonotic reservoirs and cause significant morbidity and mortality in the human population. Three coronaviruses emerged and caused significant human outbreaks in recent history: severe acute respiratory syndrome coronavirus (SARS-CoV-1) in 2003, Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 2019. The coronavirus spike protein facilitates viral entry into target cells by engaging the host receptors and fusing the viral and host membrane together. As the primary determinant of viral entry into target cells, the coronavirus spike protein is the target of most vaccines and therapeutics. Antibodies induced by prior infection and vaccination and therapeutics may select for spike protein mutations that evade these antibodies without disrupting the spike protein's ability to engage the host receptor and mediate membrane fusion. In the following dissertation, I detail a unique mechanism of antibody evasion induced by a mutation in the receptor binding domain of the SARS-CoV-2 spike protein. I additionally describe the impact of spike protein mutations observed in the SARS-CoV-2 Omicron variants on receptor engagement, fusogenicity, and evasion from infection- and vaccine-elicited antibodies. I further examine how updated SARS-CoV-2 vaccine formulations shape the humoral immune response. Finally, I detail the contribution of spike protein domains and epitopes to the neutralizing activity of convalescent plasma collected from individuals infected with MERS-CoV. Collectively, my work is informing the development of the next generation of coronavirus vaccines and therapeutics.
Contained By:	Dissertations Abstracts International85-10B.
標題:	Virology. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30988463
ISBN:	9798382211145

Properties of Coronavirus Spike Proteins and the Antibody Responses Against Them /
Addetia, Amin,

Properties of Coronavirus Spike Proteins and the Antibody Responses Against Them /Amin Addetia. - 1 electronic resource (263 pages)

Source: Dissertations Abstracts International, Volume: 85-10, Section: B.

Coronaviruses have a propensity to spillover from zoonotic reservoirs and cause significant morbidity and mortality in the human population. Three coronaviruses emerged and caused significant human outbreaks in recent history: severe acute respiratory syndrome coronavirus (SARS-CoV-1) in 2003, Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 2019. The coronavirus spike protein facilitates viral entry into target cells by engaging the host receptors and fusing the viral and host membrane together. As the primary determinant of viral entry into target cells, the coronavirus spike protein is the target of most vaccines and therapeutics. Antibodies induced by prior infection and vaccination and therapeutics may select for spike protein mutations that evade these antibodies without disrupting the spike protein's ability to engage the host receptor and mediate membrane fusion. In the following dissertation, I detail a unique mechanism of antibody evasion induced by a mutation in the receptor binding domain of the SARS-CoV-2 spike protein. I additionally describe the impact of spike protein mutations observed in the SARS-CoV-2 Omicron variants on receptor engagement, fusogenicity, and evasion from infection- and vaccine-elicited antibodies. I further examine how updated SARS-CoV-2 vaccine formulations shape the humoral immune response. Finally, I detail the contribution of spike protein domains and epitopes to the neutralizing activity of convalescent plasma collected from individuals infected with MERS-CoV. Collectively, my work is informing the development of the next generation of coronavirus vaccines and therapeutics.

English

ISBN: 9798382211145Subjects--Topical Terms:

187922
Virology.
Subjects--Index Terms:

Coronaviruses

Properties of Coronavirus Spike Proteins and the Antibody Responses Against Them /
LDR:03157nam a22004213i 4500 001 391398
005 20251124054751.5
006 m o d
007 cr|nu||||||||
008 251208s2024 miu||||||m |||||||eng d
020 $a 9798382211145
035 $a (MiAaPQD)AAI30988463
035 $a AAI30988463
040 $a MiAaPQD $b eng $c MiAaPQD $e rda
100 1 $a Addetia, Amin, $e author. $3 523826
245 1 0 $a Properties of Coronavirus Spike Proteins and the Antibody Responses Against Them / $c Amin Addetia.
264 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2024
300 $a 1 electronic resource (263 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 85-10, Section: B.
500 $a Advisors: Veesler, David J. Committee members: Bloom, Jesse D.; Greninger, Alex.
502 $b Ph.D. $c University of Washington $d 2024.
520 $a Coronaviruses have a propensity to spillover from zoonotic reservoirs and cause significant morbidity and mortality in the human population. Three coronaviruses emerged and caused significant human outbreaks in recent history: severe acute respiratory syndrome coronavirus (SARS-CoV-1) in 2003, Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 2019. The coronavirus spike protein facilitates viral entry into target cells by engaging the host receptors and fusing the viral and host membrane together. As the primary determinant of viral entry into target cells, the coronavirus spike protein is the target of most vaccines and therapeutics. Antibodies induced by prior infection and vaccination and therapeutics may select for spike protein mutations that evade these antibodies without disrupting the spike protein's ability to engage the host receptor and mediate membrane fusion. In the following dissertation, I detail a unique mechanism of antibody evasion induced by a mutation in the receptor binding domain of the SARS-CoV-2 spike protein. I additionally describe the impact of spike protein mutations observed in the SARS-CoV-2 Omicron variants on receptor engagement, fusogenicity, and evasion from infection- and vaccine-elicited antibodies. I further examine how updated SARS-CoV-2 vaccine formulations shape the humoral immune response. Finally, I detail the contribution of spike protein domains and epitopes to the neutralizing activity of convalescent plasma collected from individuals infected with MERS-CoV. Collectively, my work is informing the development of the next generation of coronavirus vaccines and therapeutics.
546 $a English
590 $a School code: 0250
650 4 $2 96060 $a Virology. $3 187922
650 4 $2 96060 $a Immunology. $3 187040
650 4 $2 96060 $a Biochemistry. $3 186550
653 $a Coronaviruses
653 $a Respiratory syndrome
653 $a Immune response
653 $a Vaccines
690 $a 0487
690 $a 0982
690 $a 0720
710 2 $a University of Washington. $b Molecular and Cellular Biology. $e degree granting institution. $3 523827
720 1 $a Veesler, David J. $e degree supervisor.
773 0 $t Dissertations Abstracts International $g 85-10B.
790 $a 0250
791 $a Ph.D.
792 $a 2024
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30988463

筆 0 讀者評論

多媒體

評論

新增評論分享你的心得，請勿在此評論區張貼涉及人身攻擊、情緒謾罵、或內容涉及非法的不當言論，館方有權利刪除任何違反評論規則之發言，情節嚴重者一律停權，以維護所有讀者的自由言論空間。

Export

取書館別